The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
In vivo genome editing restores haemostasis in a mouse model of haemophilia
Open accessAbstract
Editing of the human genome to correct disease-causing mutations is a promising approach for the treatment of genetic disorders. Genome editing improves on simple gene-replacement strategies by effecting in situ correction of a mutant gene, thus restoring normal gene function under the control of endogenous regulatory elements and reducing risks associated with random insertion into the genome. Gene-specific targeting has historically been limited to mouse embryonic stem cells. The development of zinc finger nucleases (ZFNs) has permitted efficient genome editing in transformed and primary cells that were previously thought to be intractable to such genetic manipulation. In vitro, ZFNs have been shown to promote efficient genome editing via homology-directed repair by inducing a site-specific double-strand break (DSB) at a target locus, but it is unclear whether ZFNs can induce DSBs and stimulate genome editing at a clinically meaningful level in vivo. Here we show that ZFNs are able to induce DSBs efficiently when delivered directly to mouse liver and that, when co-delivered with an appropriately designed gene-targeting vector, they can stimulate gene replacement through both homology-directed and homology-independent targeted gene insertion at the ZFN-specified locus. The level of gene targeting achieved was sufficient to correct the prolonged clotting times in a mouse model of haemophilia B, and remained persistent after induced liver regeneration. Thus, ZFN-driven gene correction can be achieved in vivo, raising the possibility of genome editing as a viable strategy for the treatment of genetic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the initial efficiency of repair using zinc finger nucleases was also low and was substantially improved by subsequent work to correct hemophilia in mice12.”
From Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype (2014) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M. P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C. S., Pawliuk, R., Morillon, E., et al. (2003) · Science · doi:10.1126/science.1088547 · Cited by 3,587
Genome editing with engineered zinc finger nucleases
Urnov, F. D., Rebar, E. J., Holmes, M. C., Zhang, H. S., & Gregory, P. D. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2842 · Cited by 2,285
Self-citationManno, C. S., Pierce, G. F., Arruda, V. R., Glader, B., Ragni, M., Rasko, J. J. E., Ozelo, M. C., Hoots, K., Blatt, P., Konkle, B., et al. (2006) · Nature Medicine · doi:10.1038/nm1358 · Cited by 2,163
Self-citationSafety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K. A., Testa, F., Surace, E. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802315 · Cited by 2,145
Self-citationEffect of gene therapy on visual function in Leber’s congenital amaurosis
Bainbridge, J. W. B., Smith, A. J., Barker, S. S., Robbie, S., Henderson, R., Balaggan, K., Viswanathan, A., Holder, G. E., Stockman, A., Tyler, N., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802268 · Cited by 1,924
Highly efficient endogenous human gene correction using designed zinc-finger nucleases
Urnov, F. D., Miller, J. C., Lee, Y.-L., Beausejour, C. M., Rock, J. M., Augustus, S., Jamieson, A. C., Porteus, M. H., Gregory, P. D., & Holmes, M. C. (2005) · Nature · doi:10.1038/nature03556 · Cited by 1,642
Self-citationTreatment of Sickle Cell Anemia Mouse Model with iPS Cells Generated from Autologous Skin
Hanna, J. H., Wernig, M., Markoulaki, S., Sun, C., Meissner, A., Cassady, J. P., Beard, C., Brambrink, T., Wu, L.-C., Townes, T. M., et al. (2007) · Science · doi:10.1126/science.1152092 · Cited by 1,521
Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
Cartier, N., Hacein-Bey-Abina, S., Bartholomae, C. C., Veres, G., Schmidt, M., Kutschera, I., Vidaud, M., Abel, U., Dal-Cortivo, L., Caccavelli, L., et al. (2009) · Science · doi:10.1126/science.1171242 · Cited by 1,508
Howe, S. J., Mansour, M. R., Schwarzwaelder, K., Bartholomae, C., Hubank, M., Kempski, H., Brugman, M. H., Pike-Overzet, K., Chatters, S. J., de Ridder, D., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35798 · Cited by 1,286
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–549 of 549
Developing novel therapeutic strategies for Rett syndrome
Ross, P. D. (2016) · Enlighten: Theses (The University of Glasgow)
[Biologic treatments for hereditary diseases].
Yang, J., Xie, Y., & Chen, L. (2015) · PubMed
Engineering the zinc finger recombinase for use in targeted genomic editing
Kentner, J. L. (2015) · Enlighten: Theses (The University of Glasgow)
Designer Zinc Finger Nuclease: A Versatile Tool for Genome Editing in Animals
Lakkireddy, K., Podha, S., Krishna Satya, A., Kasturi, K. N., & Rao, K. R. S. S. (2014) · Research & Reviews: A Journal of Biotechnology
Genetic Manipulation of Human Pluripotent Stem Cells Using Zinc Finger Nucleases
Li, T., Gustin, J. A., Dodla, M. C., & Lyons, I. G. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-385473-5.00032-1
Self-citationCharacterising mechanisms of aberrant androgen receptor signalling in advanced prostate cancer
Guo, W., Robson, C. N., & Gaughan, L. (2016) · Endocrine Abstracts · doi:10.1530/endoabs.42.p23
Targeted genetic modification of the porcine genome using zinc-finger nucleases
Hauschild‐Quintern, J. (2012)
The Future for Genomic Medicine in Inflammatory Diseases
Kitson, C. (2017) · Springer eBooks · doi:10.1007/978-3-319-42252-7_4
Precision engineering of the chicken genome for disease control
Challagulla, A. (2016)
Designer Effectors for Editing and Regulating Complex Genomes
Müller, M., Mlambo, T., & Mussolino, C. (2017) · Springer eBooks · doi:10.1007/978-3-319-53457-2_7
Genetic diagnosis in patients with bleeding disorders
Yada, K., & Nogami, K. (2015) · Japanese Journal of Thrombosis and Hemostasis · doi:10.2491/jjsth.26.513
The potential of Genome-editing techniques
Ohmori, T. (2015) · Japanese Journal of Thrombosis and Hemostasis · doi:10.2491/jjsth.26.534
Elucidation of Mechanisms of Fetal Hemoglobin Regulation by CRISPR/Cas9 Mediated Genome Editing
Canver, M. C. (2016) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Research progress of hereditary blood diseases
HuiYuan, L. I., & Yang, R. (2017) · Scientia Sinica Vitae · doi:10.1360/n052017-00271
Self-citationSite‐Directed Genome Modification with Engineered Zinc Finger Proteins
Woodard, L. E., Galvan, D. L., & Wilson, M. H. (2018) · Wiley eBooks · doi:10.1002/9783527688104.ch3
Bibi, R. (2018) · Pure and Applied Biology · doi:10.19045/bspab.2018.70082
Gene Editing of Stem Cells to Model and Treat Disease
Hollywood, J. A., Sanz, D. J., Davidson, A. J., & Harrison, P. T. (2018) · Current Stem Cell Reports · doi:10.1007/s40778-018-0140-x
Genome Editing Technologies: From Bench Side to Bedside
Tuncay, F. Y., & Dinçer, P. (2018) · Acta Medica · doi:10.32552/2018.actamedica.282
Enhancing the Efficiency of CRISPR/Cas9 Precise Gene Editing for Cystic Fibrosis Gene Therapy
Seigel, K. E. (2018) · TSpace (University of Toronto)
Can Hsp Targeted Gene Therapy Be a New Hope for Gliomas?
Uçar, E. Ö., Şengelen, A., Güngör, E., Mertoğlu, E., Pekmez, M., & Arda, N. (2019) · Heat shock proteins · doi:10.1007/978-3-030-24285-5_13
Genome editing tools and its potential applications in translational medicine- a brief overview.
Pillai, A. B., & Elanthiraiyan, S. (2016) · Annals of SBV · doi:10.5005/jp-journals-10085-5104
Musunuru, K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823484-6.00008-6
Application of Genome Editing Technologies for Disease Treatment: Review
Belachew, G. T., Paramesh, H., & Tekelemariam, B. A. (2021) · Journal of Pharmaceutical Research International · doi:10.9734/jpri/2021/v33i19a31320
Faculty Opinions recommendation of Pleiotropy in complex traits: challenges and strategies.
Tiemeier, H. W. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.718019787.793478516
Mingozzi, F., & Junge, N. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-63671-1.00033-1
Genome‐Editing Applications in Stem Cell Engineering and Regenerative Medicine
Gupta, P., Jaitly, S., Thakur, P., Goswami, S. G., Bhargava, N., & Ramalingam, S. (2022) · Wiley eBooks · doi:10.1002/9781119671404.ch17
Utilizing CRISPR/Cas9 Technologies for in vivo Disease Modeling and Therapy
Badertscher, L., & Porritt, M. J. (2022) · Wiley eBooks · doi:10.1002/9781119671404.ch7
Lysosomal storage disorders with neurological manifestations
Munjal, V., Clarke, M. T., Vignolles‐Jeong, J., Valencia, J. A., Travis, M., & Samaranch, L. (2022) · Rare Disease and Orphan Drugs Journal · doi:10.20517/rdodj.2021.05
(2011) · Nature Medicine · doi:10.1038/nm0811-938
Design of efficacious somatic cell genome editing strategies for recessive and polygenic diseasesPreprint
Carlson-Stevermer, J., Das, A., Abdeen, A. A., Fiflis, D. N., Grindel, B. I., Akcan, T., Alam, T., Kletzien, H., Kohlenberg, L. K., Goedland, M., et al. (2020) · doi:10.21203/rs.3.rs-90150/v1
Fehlings, M. G. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734958350.793573257
Faculty Opinions recommendation of Efficient In Vivo Liver-Directed Gene Editing Using CRISPR/Cas9.
Conboy, I. M. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732930845.793553932
大森, 司. (2018) · Japanese Journal of Thrombosis and Hemostasis · doi:10.2491/jjsth.29.760
The Basics of Molecular Pathology
(2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415944-0.00002-4
Assaf, B. T., Harper, C. G., & Phillips, J. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821047-5.00034-8
Gene Editing in ErbB/HER Family-Mediated Cancer Immunology
Yin, L. (2025) · Genetics. · doi:10.5772/intechopen.1008441
Prospects for using gene therapy drugs in the treatment of cystic fibrosis
Demidova, A. D., & Zavadskiy, S. P. (2025) · Farmacevticheskoe delo i tehnologija lekarstv (Pharmacy and Pharmaceutical Technology) · doi:10.33920/med-13-2501-04
Lentz, P. (n.d.) · ProQuest Demo Repository
Walsh, C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800563-7.00013-0
Balancing Promise and Peril: Hemophilia Gene Therapy Insights
Akula, S., Borroni, E., Cottonaro, A., Follenzi, A., & Merlin, S. (2026) · IUBMB Life · doi:10.1002/iub.70087
Exploring gene editing as a potential therapeutic strategy for hemophilia
Kumarasamy, N., & Balakrishnan, B. (2026) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2026.1727204
Bella, T. L. (2018) · theses.fr (ABES) · doi:10.70675/e88d9a08za929z4c0fzb8d9z9f01cd69ca39
Ex vivo gene therapy for β-hemoglobinpathies and metabolic disorders
Laurent, M. (2023) · theses.fr (ABES) · doi:10.70675/ba5c585dzaa79z48d2z9f40zfee1cdd49d32
Advancements in CRISPR-based in vivo gene therapy for hemophilia
Zhang, X., Xu, K., Zou, S., Zhu, Z., Teng, S., & Huang, P. (2026) · Frontiers in Genome Editing · doi:10.3389/fgeed.2026.1924733
Nonclinical Evaluation of Gene-Editing Products
(2026) · Elsevier eBooks · doi:10.1016/b978-0-443-48612-8.00016-6
Metadata
- Authors
- Li, H., Haurigot, V., Doyon, Y., Li, T., Wong, S. Y., Bhagwat, A. S., Malani, N., Anguela, X. M., Sharma, R., Ivanciu, L., Murphy, S. L., Finn, J. D., Khazi, F. R., Zhou, S., Paschon, D. E., Rebar, E. J., Bushman, F. D., Gregory, P. D., Holmes, M. C., & High, K. A.
- Affiliations
- Children's Hospital of Philadelphia (US)
- Sangamo BioSciences (United States) (US)
- University of Pennsylvania (US)
- Corresponding author
- Holmes, Michael C.
- High, Katherine A.
- ORCID
- Venue
- Nature
- Published
- 2011-06-26
- Volume
- 475
- Issue
- 7355
- Pages
- 217-221
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3152293
- OpenAlex
- W2038866304
- Cited by
- 548
- References
- 29
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 12 · 2023: 13 · 2022: 22 · 2021: 19 · 2020: 34 · 2019: 33 · 2018: 48 · 2017: 54 · 2016: 66 · 2015: 62 · 2014: 66 · 2013: 44 · 2012: 40
- FWCI
- 35.43
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Heart, Lung, and Blood Institute (P01HL064190, T32HL007150)
- Topics
- Health Sciences › Medicine › Hematology › Hemophilia Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- zinc finger nucleases, genome editing, hemophilia B, in vivo gene targeting, DNA double-strand breaks, homology-directed repair, gene replacement, liver regeneration, genetic disease treatment
- MeSH terms
- Animals, Base Sequence, Hemophilia B, Disease Models, Animal, DNA Repair, Endonucleases, Exons, Factor IX, Genetic Vectors, Hemostasis, Humans, Introns, Liver, Liver Regeneration, Mice, Inbred C57BL, Mutation, Phenotype, Genetic Therapy, Zinc Fingers, Genome, Sequence Homology, Gene Targeting, Cell Line, Tumor, Mice, DNA Breaks, Double-Stranded, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
